Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gastroesophageal reflux and chronic cough.

Literature DB >> 10950100

Gastroesophageal reflux and chronic cough.

R S Irwin¹, J E Richter.

Abstract

Entities: Disease

Mesh：

Year: 2000 PMID： 10950100 DOI： 10.1016/s0002-9270(00)01073-x

Source DB: PubMed Journal: Am J Gastroenterol ISSN： 0002-9270 Impact factor: 10.864

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

Review 1. Atypical manifestations of gastroesophageal reflux disease.

Authors: Michael F Vaezi
Journal: MedGenMed Date: 2005-10-27

2. Approach to chronic cough.

Authors: Keya Rani Lahiri; Amruta Avinash Landge
Journal: Indian J Pediatr Date: 2014-04-22 Impact factor: 1.967

3. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease.

Authors: Maria Pina Dore; Antonietta Pedroni; Gianni M Pes; Emanouil Maragkoudakis; Vincenza Tadeu; Pietro Pirina; Giuseppe Realdi; Giuseppe Delitala; Hoda M Malaty
Journal: Dig Dis Sci Date: 2007-01-09 Impact factor: 3.199

4. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.

Authors: Fabio Baldi; Roberta Cappiello; Carlotta Cavoli; Stefania Ghersi; Francesco Torresan; Enrico Roda
Journal: World J Gastroenterol Date: 2006-01-07 Impact factor: 5.742

Review 5. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs.

Authors: J Dent; D Armstrong; B Delaney; P Moayyedi; N J Talley; N Vakil
Journal: Gut Date: 2004-05 Impact factor: 23.059

6. Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models.

Authors: Robbie L McLeod; Deen B Tulshian; Donald C Bolser; Geoffrey B Varty; Marco Baptista; Xiomara Fernandez; Leonard E Parra; Jennifer C Zimmer; Christine H Erickson; Ginny D Ho; Yanlin Jia; Fay W Ng; Walter Korfmacher; Xiaoying Xu; John Veals; April Smith-Torhan; Samuel Wainhaus; Ahmad B Fawzi; Theodore M Austin; Margaret van Heek; John A Hey
Journal: Eur J Pharmacol Date: 2009-12-16 Impact factor: 4.432

Gastroesophageal reflux and chronic cough.

Review 1. Atypical manifestations of gastroesophageal reflux disease.

2. Approach to chronic cough.

3. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease.

4. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.

Review 5. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs.

6. Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical models.

Review 7. Gastroesophageal reflux disease and chronic cough.

Review 8. The role of proton pump inhibitors in gastro-oesophageal reflux disease.

Review 9. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease.

10. Pulmonary manifestations of gastroesophageal reflux disease.